Salute e Benessere

LIfT BioSciences heralds a new era of affordable effective cancer cell therapies…

LIfT BioSciencesheralds a new era of affordable effective cancer cell therapies simply produced from iPSCsLIfT announces successful production of first-in-class neutrophil based cell therapy from iPSCsUse of iPSCs will enable production ofa truly off-the-shelf cell therapyfor all cancer patients without the ongoing need for stem cell donorsLondon,6July 2023– LIfT BioSciences, ('LifT' or 'the Company'), a rapidly emerging...
Nasdaq GlobeNewswire
06/07/2023

Groundbreaking new £100m LifeArc programme aims to improve the lives of people…

MEDIA RELEASEGroundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare diseaseSelf-funded medical research organisation and charity, LifeArc, to launch a groundbreaking Rare Disease Translational Challenge that will invest more than £100m by 2030 to improve the lives of people living with a rare disease.The Challenge will offer funding and support to researchers to help find new diagnostic technologies, develop new...
Nasdaq GlobeNewswire
06/07/2023

Seasoned Healthcare Executive David Bassin Joins the MolecuLight Board of…

David Bassin brings a wealth of expertise and experience in the healthcare industry, particularly in the field of wound care. As the founder of GIO Advisory LLC, he has provided invaluable advisory services to numerous companies and private equity firms based on his extensive background in healthcare, spanning pharmaceutical/device, payer, and provider services. Most recently, Bassin served as the CEO of Healogics, the foremost provider of wound care services in the US, operating over 630 wound…
PR Newswire
06/07/2023

1,000th alfapump® implant completed

Extensive real world alfapumpexperience derisks planned US & Canadian launchStrong clinical alfapumpprofile demonstrated in North American POSEIDON studyAll approvals received to commence US MOJAVE study of DSR 2.0 Ghent, Belgium – 06July2023– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today...
Nasdaq GlobeNewswire
06/07/2023

Prostate Cancer Global Market to Witness Upsurge in Growth at a CAGR of ~5% by…

Key Takeaways from the Prostate Cancer Market Report Key Takeaways from the Prostate Cancer Market Report To read more about the latest highlights related to the Prostate Cancer market, get a snapshot of the key highlights entailed in theGlobal Prostate Cancer Market Report Prostate Cancer Overview Prostate cancer is a cancer that develops in the prostate gland. Inthe United States, it is the second greatest cause of cancer death in men. Prostate cancer affects one out of...
PR Newswire
05/07/2023

Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext GrowthISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting rights 06/30/202355,583,76861,505,063About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR-T...
Nasdaq GlobeNewswire
05/07/2023

ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care…

Expands ResMed's sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatmentDiagnostic management platform is upstream of and complementary to ResMed's current post-testing AirView and Brightree offeringsSomnoware platform will remain an open platform to enable sleep labs, pulmonary function testing facilities, and physicians to view results from various testing solutions and help diagnosed...
Nasdaq GlobeNewswire
05/07/2023

Active Pharmaceutical Ingredients (API) Market Outlook 2028, the Market to…

Browse In-Depth TOC on Active Pharmaceutical Ingredients (API) Market 194 – Tables 160 – Charts 373 – Pages Browse In-Depth TOC on Active Pharmaceutical Ingredients (API) Market 194 – Tables 160 – Charts 373 – Pages Increased demand for generic drugs can have a positive effect on APIs. This is because more generic drug producers require higher volumes of APIs for their production processes. This increase in demand for APIs can lead to more manufacturing of APIs by bulk...
PR Newswire
05/07/2023

The Europe Probiotics Market to Worth $18.76 Billion by 2028 - Arizton

To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3831 To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3831 Browse In-Depth TOC on Europe Probiotics Market 108 – Tables 92 – Charts 244 – Pages Probiotic-based products are used to improve the immune system. Due to the COVID-19 pandemic, awareness about the good immune system and its long-term benefits is increasing. Thus, people prefer probiotics...
PR Newswire
05/07/2023

NFL BIOSCIENCES: CO-FOUNDER SHAREHOLDER FURTHER STRENGTHENS HIS POSITION BY…

NFL BIOSCIENCES: CO-FOUNDER SHAREHOLDER FURTHER STRENGTHENS HIS POSITION BY EXERCISING “BSPCE” WARRANTSNFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, has beeninformed that 50,000 BSPCE company founder warrants (“BSPCE warrants”) held by Mr Bruno Lafont, Chief Operating Officer and co-founder of NFL Biosciences, have been exercised, giving him the right to subscribe 500,000 new...
Nasdaq GlobeNewswire
05/07/2023

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Regulated InformationLeuven, BELGIUM, Boston, MA, US – July 5 , 2023 – 7 .00PM CETOxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has received transparency notifications as follows: Oxurion received a transparency notification on July 5, 2023, from...
Nasdaq GlobeNewswire
05/07/2023

Ambulatory Polysomnography (PSG) Systems Market to Exhibit 6.0% CAGR and…

As per the report published by Research Dive, the global ambulatory polysomnography (PSG) systems market is expected to register a revenue of $570.7 million by 2031 at a CAGR of 6.0% during the forecast period 2022-2031. As per the report published by Research Dive,the global ambulatory polysomnography (PSG) systems market is expected to register a revenue of$570.7 millionby 2031 at a CAGR of 6.0% during the forecast period 2022-2031. Segments of the Ambulatory Polysomnography...
PR Newswire
05/07/2023

High-Throughput Screening (HTS) Market worth $44.5 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950 Browse in-depth TOC on "High-Throughput Screening (HTS) Market" 471 - Tables 49 - Figures 373 - Pages High-Throughput Screening (HTS) Market Scope: The consumables segment accounted for the largest share, by application in the high-throughput screening (HTS) market in...
PR Newswire
05/07/2023

Chemiluminescence Immunoassay Market worth $19.0 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131865271 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131865271 Browse in-depth TOC on "Chemiluminescence Immunoassay Market" 181 - Tables 52 - Figures 283 - Pages Chemiluminescence Immunoassay Market Scope: In 2022, the consumables segment held the largest share of the chemiluminescence market, by product segment Based on...
PR Newswire
05/07/2023

Endoscopic Submucosal Dissection Market To Touch USD 512.9 Million by 2030…

Endoscopic Submucosal Dissection Most Widely Performed for Stomach Cancer Endoscopic Submucosal Dissection Most Widely Performed for Stomach Cancer Get the sample pages of this report:https://www.psmarketresearch.com/market-analysis/endoscopic-submucosal-dissection-market/report-sample ESDs Are Most Commonly Performed in Hospitals Hospitals had the dominant share, of 60%, in 2022, as numerous hospitals worldwide are choosing this cost-effective surgical technique. Further,...
PR Newswire
05/07/2023

LIFERA, SANOFI and ARABIO Sign MOU to Manufacture and Supply Vaccines in Saudi…

Dr. Ibrahim AljufalliChairman of the Lifera Board, said:"As a newly established biopharmaceutical company, we are committed to working with global and local partners to achieve our mission – and this MOU is a testament to that commitment. By collaborating with Sanofi, an innovative global healthcare leader, Lifera is facilitating the transfer of world-class technology and expertise to Saudi Arabia and most importantly, bringing the highest-quality vaccines to Saudi citizens, enhancing…
PR Newswire
05/07/2023

Artificial Organs and Bionic Implants Market to Reach $92.1 Billion, Globally…

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/14729 Download Sample Copy-https://www.alliedmarketresearch.com/request-sample/14729 Prime determinants of growth Increase in heart diseases, increase in arthritis, rise in accidents & osteoporosis which further lead to bone fracture and damage of body parts, rise in demand for artificial organs and bionic implants, and rise in research and development of artificial organs and bionic implants drive...
PR Newswire
05/07/2023

Pharmaceutical Drug Delivery Market to Reach $2,307.27 Billion, Globally, by…

Download Sample Copy- https://www.alliedmarketresearch.com/request-sample/6467 Download Sample Copy-https://www.alliedmarketresearch.com/request-sample/6467 Prime determinants of growth Increase in prevalence of chronic diseases due to changing lifestyle, increase in smoking population, and development of advanced drug delivery products drive the growth of the global pharmaceutical drug delivery market. However, strict government regulations for the approval of new...
PR Newswire
05/07/2023

The Conjugation and Labeling Services Market is projected to grow at a CAGR of…

The growing interest of various stakeholders in conjugated and labeled molecules for therapeutic and diagnostic applications had led to a surge in demand for these complex molecules. The conjugates / labels incorporated in the molecules are known to offer target specificity, bioavailability, improved pharmacokinetic property and membrane permeability. Moreover, these bioconjugates support the robust and sensitive detection of the target molecule of interest. The construction of homogenous…
PR Newswire
05/07/2023

Pioneer of Refractive Surgery to Join Advisory Board of Evolution Optiks

Evolution Optiks has developed a portable fully digital light field tele-refractor that enables eye exams to be conducted anywhere in the world, without the practitioner having to be present. "We are thrilled to welcome Thomas as an Advisory Board member. In addition to his great expertise and decades of experience in ophthalmology, he shares our pioneering spirit of research and a keen interest in innovation. His knowledge and guidance will help us to unlock the virtually endless…
PR Newswire
05/07/2023

Akari Therapeutics Appoints Industry Veteran Wa'el Hashad to Board of Directors

NEW YORK and LONDON, July05, 2023(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the appointment of industry veteran Wa'el Hashad to the Akari Board of Directors as an independent director. Mr. Hashad, who will serve on both the Audit Committee and Nominating and Governance Committee, brings more than 35 years of biopharmaceutical experience to Akari's...
Nasdaq GlobeNewswire
05/07/2023

Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals

The new agreement expands Pheon's ADC pipeline which boasts first-in-class and best-in-class ADCs to meet significant unmet clinical needs in oncology. Pheon launched in March 2022 with a $68 million Series A financing is led by a strong leadership team of specialists in targeted oncology therapies and ADCs. The new agreement expands Pheon's ADC pipeline which boasts first-in-class and best-in-class ADCs to meet significant unmet clinical needs in oncology. Pheon launched inMarch 2022with a...
PR Newswire
05/07/2023

Curaleaf International Subsidiary to Acquire Clever Leaves' EU-GMP Certified…

The state-of-the-art facility, which measures over 900 square meters of GMP factory space and 750 square meters of warehousing, will process flower grown at Terra Verde, Curaleaf's Cultivation facility located in Alcochete, Portugal. These changes will allow Curaleaf to strategically expand its cultivation capacity at Terra Verde to meet the expected growth across Europe, especially within the core markets of the UK and Germany. The state-of-the-art facility, which measures over 900 square...
PR Newswire
05/07/2023

Affidea expands in Portugal with the acquisition of Clínica Radiologia de…

Clínica do Coração do Alentejo, established in 2009, stands as a reference centre for cardiology in Evora region. The clinic not only excels in cardiology but also offers a diverse range of services in other sub-specialties such as Psychiatry, Dermatology, Internal Medicine, Pneumology, Rheumatology, and Urology. Clínica do Coração do Alentejo, established in 2009, stands as a reference centre for cardiology in Evora region. The clinic not only excels in cardiology but also offers a diverse...
PR Newswire
05/07/2023
Altri  Comunicati